Mitsubishi UFJ Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,070
Closed -$6.9M 1165
2022
Q3
$6.9M Buy
28,070
+1,383
+5% +$373K 0.02% 487
2022
Q2
$6.61M Buy
26,687
+1,910
+8% +$515K 0.03% 497
2022
Q1
$8.21M Buy
24,777
+3,320
+15% +$1.02M 0.03% 472
2021
Q4
$7.86M Buy
21,457
+1,789
+9% +$604K 0.03% 498
2021
Q3
$6.4M Buy
19,668
+2,727
+16% +$924K 0.03% 505
2021
Q2
$5.29M Buy
16,941
+1,499
+10% +$460K 0.03% 540
2021
Q1
$4.92M Buy
15,442
+1,677
+12% +$537K 0.03% 506
2020
Q4
$4.46M Buy
13,765
+1,065
+8% +$295K 0.03% 471
2020
Q3
$3.52M Buy
12,700
+1,669
+15% +$481K 0.03% 456
2020
Q2
$2.67M Buy
11,031
+1,095
+11% +$220K 0.03% 466
2020
Q1
$1.44M Sell
9,936
-625
-6% -$104K 0.02% 547
2019
Q4
$1.76M Buy
10,561
+2,007
+23% +$372K 0.02% 572
2019
Q3
$1.52M Sell
8,554
-3,315
-28% -$717K 0.02% 529
2019
Q2
$3.09M Buy
11,869
+2,397
+25% +$636K 0.05% 352
2019
Q1
$2.71M Buy
9,472
+1,745
+23% +$580K 0.06% 327
2018
Q4
$2.34M Sell
7,727
-1,682
-18% -$584K 0.06% 308
2018
Q3
$4.23M Buy
9,409
+3,067
+48% +$1.21M 0.09% 221
2018
Q2
$2.59M Buy
6,342
+5,430
+595% +$1.97M 0.06% 324
2018
Q1
$265K Sell
912
-32
-3% -$8.11K 0.01% 738
2017
Q4
$185K Sell
944
-26
-3% -$4.85K ﹤0.01% 753
2017
Q3
$164K Sell
970
-44
-4% -$6.65K ﹤0.01% 757
2017
Q2
$145K Sell
1,014
-58
-5% -$7.79K ﹤0.01% 769
2017
Q1
$134K Sell
1,072
-100
-9% -$11.6K ﹤0.01% 764
2016
Q4
$132K Sell
1,172
-33
-3% -$3.82K ﹤0.01% 768
2016
Q3
$155K Sell
1,205
-38
-3% -$4.55K ﹤0.01% 749
2016
Q2
$136K Buy
1,243
+278
+29% +$27.7K ﹤0.01% 755
2016
Q1
$91K Buy
965
+39
+4% +$3.29K ﹤0.01% 777
2015
Q4
$84K Buy
+926
New +$78.6K ﹤0.01% 781

Other funds holding ABMD

Mitsubishi UFJ Asset Management's ABMD Position: Q4 2022 in Review

Mitsubishi UFJ Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 28,070 shares — an estimated $6.9M sold.

Mitsubishi UFJ Asset Management first reported a position in ABMD in Q4 2015 and held it in 28 quarters. The position peaked at $8.21M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Mitsubishi UFJ Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 28,070 Abiomed Inc shares in Q4 2022, an estimated $6.9M.
  • Mitsubishi UFJ Asset Management first reported a position in Abiomed Inc in Q4 2015 and held it in 28 quarters.
  • Mitsubishi UFJ Asset Management's Abiomed Inc position peaked at $8.21M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.